Bahar Çiftçi | Health Professions | Editorial Board Member

Published on 19/11/202519/11/2025 by TOT Awards

Assoc Prof Dr. Bahar Çiftçi | Health Professions | Editorial Board Member

Atatürk University | Turkey

Assoc Prof Dr. Bahar Çiftçi is a distinguished nursing researcher whose scholarly contributions have significantly advanced knowledge in clinical nursing practice, psychiatric care, patient education, and nursing student development. Her research portfolio spans critical themes such as treatment adherence in chronic diseases, mental-health-related self-care agency, resilience and wellbeing among nursing students, disaster-related psychological outcomes, intercultural sensitivity, compassion competence, and innovative teaching strategies including Kahoot-based and question-answer reinforcement methods. She has also produced influential work on rational drug use in children, subcutaneous heparin administration, missed nursing care, clinical decision-making, and spirituality-related competencies, reflecting a strong commitment to evidence-based and human-centered nursing. Her studies published in journals such as Journal of Vascular Nursing, Perspectives in Psychiatric Care, Nurse Education Today, Journal of Community Psychology, American Journal of Critical Care, and others demonstrate her methodological expertise and interdisciplinary engagement. With a growing international footprint, she contributes to global nursing knowledge through collaborative, multi-centric research addressing contemporary healthcare challenges, including post-COVID psychological growth, hospital care quality, and professional attitudes during pandemics. Her scholarly impact is reflected in Google Scholar metrics with 582 total citations, an h-index of 14, and an i10-index of 19, alongside a strong citation trend. Scopus-indexed documents further validate the visibility and academic reach of her work within the global research community. As an editorial board member, she plays an active role in shaping scientific standards and supporting high-quality peer-reviewed publications. Collectively, her research advances both theoretical understanding and practical innovation in nursing, positioning her as a respected scholar whose work informs patient care, nursing education, and mental health practices across diverse healthcare settings.

Publication Profile

Google Scholar

Featured Publications

Turan, G. B., Aksoy, M., & Çiftçi, B. (2019). Effect of social support on the treatment adherence of hypertension patients. Journal of Vascular Nursing, 37(1), 46–51.
Bahçecioğlu Turan, G., Özer, Z., & Ciftci, B. (2021). Analysis of anxiety levels and attitudes of nursing students toward the nursing profession during the COVID‐19 pandemic. Perspectives in Psychiatric Care, 57(4), 1913–1921.
Aras, G. N., & Çiftçi, B. (2021). Comparison of the effect of reinforcement with question-answer and Kahoot method on the success and motivation levels of nursing students: A quasi-experimental review. Nurse Education Today, Article 104930.
Çiftçi, B., Yıldırım, N., Altun, Ö. Ş., & Avşar, G. (2015). What level of self-care agency in mental illness? The factors affecting self-care agency and self-care agency in patients with mental illness. Archives of Psychiatric Nursing, 29(6), 372–376.
Yıldırım, N., Çiftçi, B., & Kaşıkçı, M. (2017). Hemşirelerin hasta eğitimi verme durumu ve etkileyen faktörlerin belirlenmesi. Atatürk İletişim Dergisi, 217–231.

Alexander Panichev | Life Sciences | Best Researcher Award

Published on 15/11/202518/11/2025 by TOT Awards

Mr. Alexander Panichev | Life Sciences | Best Researcher Award

Russian Academy of Sciences | Russia

Mr. Alexander Panichev is a leading scholar in medical geology and geochemistry whose pioneering research has reshaped global understanding of geophagy–lithophagy in animals and humans. Throughout his long scientific career, he has focused on uncovering the fundamental causes, ecological drivers, and physiological mechanisms behind the instinctive consumption of earth materials. His interdisciplinary work bridges geology, biology, medicine, and geography, contributing a robust conceptual framework explaining geophagy as an autoregulatory response linked to mineral imbalance and rare earth element (REE) disruption in the neuroimmunoendocrine system. Panichev’s breakthrough discovery of an ion-exchange mechanism in organisms, along with his evidence-based theory identifying REEs as critical factors influencing mineral homeostasis, has opened new dimensions in understanding stress adaptation, ecosystem health, and geochemically conditioned endemic diseases. His research has revealed connections between REE anomalies and a spectrum of pathologies, including neurodegenerative, fibrotic, and hematopoietic disorders, offering novel perspectives for future biomedical and ecological applications. He has authored over 240 scientific works, including dozens of high-impact journal publications and multiple books that have significantly influenced the fields of geochemistry, environmental health, and medical geography. Panichev’s publication metrics reflect the global relevance of his work, with Scopus recording 273 citations across 47 documents with an h-index of 10, and Google Scholar showing substantially higher citation visibility across his extensive body of literature. His contributions continue to advance scientific inquiry and interdisciplinary collaboration, positioning him as a distinguished candidate for the Best Researcher Award.

Publication Profile

Scopus

Featured Publications

Panichev, A., & Golokhvast, K. (2025). Major and minor causes of geophagy–lithophagy in animals and humans. Geosciences, 15, 75.
[Authors list incomplete in source]. (2025). Geophagy among wild ungulates in landscapes of Yakutia with low contents of rare earth elements. Bulletin of the Tomsk Polytechnic University Geo Assets Engineering.
(Citation data: 0; Journal reference: 2025. Full author list not visible in provided text.)
Lebedeva, E., Panichev, A., Kiselev, K., Ruseva, Y., & Zaitseva, E. (2024). Taxonomic composition and physiological and biochemical properties of cultivated microorganisms isolated from kudurite rocks of the Primorsky Krai and the Republic of Altai (Russia). Microbe, 5, 100214. https://doi.org/10.1016/j.microb.2024.100214
Panichev, A., Baranovskaya, N., Chekryzhov, I., Ivanov, V., & Ysatska, A. (2024). An unusual variety of geophagy: Coal consumption by snow sheep in the Transbaikalia Mountains. Doklady Earth Sciences, 507(1), 964–967. https://doi.org/10.1134/s1028334x22700453

Joan-Lluis Vives Corrons | Health Sciences | Outstanding Scientist Award

Published on 16/10/202516/10/2025 by TOT Awards

Prof. Joan-Lluis Vives Corrons | Health Sciences | Outstanding Scientist Award

Academic Background

Prof. Joan-Lluis Vives-Corrons holds a Medical Doctor degree and is a specialist in Haematology from the University of Barcelona. He completed advanced training as a fellow at Hôpital Beaujon in Paris and as a visiting fellow at The Scripps Research Institute. He has served as a professor of Medicine at the University of Barcelona and has been deeply involved in education and mentorship in haematology throughout his career. According to Scopus and Google Scholar records, his work has been cited extensively, with over 1,467 documents citing his research, 81 documents authored, and an h-index of 21, reflecting his sustained influence in the field.

Research Focus

Prof. Joan-Lluis Vives Corrons research focuses on the study of rare and congenital anaemias, encompassing the molecular and genetic mechanisms underlying red blood cell disorders. He has a strong interest in the standardization of haematology laboratory practices and in improving diagnostic approaches for haemoglobinopathies and enzymopathies. His work bridges clinical practice and translational research to advance patient care for rare anaemias.

Work Experience

Prof. Joan-Lluis Vives Corrons has held leadership roles in haematology laboratories and clinical departments, serving as head of the Haematology Laboratory and Red Cell Pathology Units at the Hospital Clinic of the University of Barcelona. He has also led the Red Cell Pathology and Haematopoietic Disorders Research Group at the Josep Carreras Institute for Leukemia Research and currently oversees the Clinical Centre for Ambulatory Medicine in Barcelona. He has coordinated large-scale networks for the diagnosis and follow-up of rare haematological disorders, contributing significantly to public health programs such as newborn screening for sickle-cell disease.

Key Contributions

Prof. Joan-Lluis Vives Corrons has pioneered the development of diagnostic methods for rare anaemias, implemented quality assessment schemes in haematology, and contributed to the standardization of automated laboratory analyzers. His research has led to the discovery of multiple novel mutations in genes responsible for red blood cell disorders, enhancing the understanding of their molecular basis. He has facilitated international collaboration through European networks for rare anaemias and supported education and training programs for haematologists and laboratory professionals.

Awards & Recognition

Recognized for his exceptional research and leadership, Prof. Vives-Corrons has been honored with the Outstanding Scientist Award for his groundbreaking contributions to the study of rare anaemias. His work is widely acknowledged for advancing clinical and laboratory haematology practice while fostering global collaborations in rare disease research.

Professional Roles & Memberships

Prof. Joan-Lluis Vives Corrons has held significant professional roles, including Secretary General of the International Society of Haematology and representative membership in the European Union Committee of Experts in Rare Diseases. He is affiliated with multiple national and international scientific societies and serves on editorial boards of leading journals in haematology. His work with ORPHANET, EURORDIS, and various standardization organizations underscores his commitment to improving rare disease diagnostics and care.

Profile

Scopus | Orcid

Featured Publications

Vives-Corrons, J. L., et al. (2024). SARS-CoV-2 infection and anemia—A focus on RBC deformability and membrane proteomics—Integrated observational prospective study. Microorganisms.

Vives-Corrons, J. L., et al. (2023). The pyruvate kinase deficiency global longitudinal (Peak) registry: Rationale and study design. BMJ Open.

Vives-Corrons, J. L., et al. (2022). Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content. Blood Cells, Molecules and Diseases.

Vives-Corrons, J. L., et al. (2022). Concomitant hereditary spherocytosis and pyruvate kinase deficiency in a Spanish family with chronic hemolytic anemia: Contribution of laser ektacytometry to clinical diagnosis. Cells.

Vives-Corrons, J. L., et al. (2022). Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants. Annals of Hematology.

Impact Statement / Vision

Prof. Joan-Lluis Vives Corrons to advance the understanding and management of rare anaemias through innovative research, international collaboration, and the integration of molecular diagnostics into clinical practice. His vision emphasizes improving patient outcomes while promoting education and quality standards in haematology worldwide.

Gülsen Kendir | Health Sciences | Best Researcher Award

Published on 24/06/202524/06/2025 by TOT Awards

Assoc. Prof. Dr. Gülsen Kendir | Health Sciences | Best Researcher Award

Associate Professor at Süleyman Demirel University, Turkey

Dr. Gülsen Kendir is an Associate Professor of Pharmaceutical Botany at Süleyman Demirel University’s Faculty of Pharmacy. She earned her PhD in 2012 from Ankara University after completing her MSc in 2005 and BSc in Biology in 2001 from Çukurova University. With expertise in medicinal plant anatomy and taxonomy, Dr. Kendir has contributed significantly to understanding Turkey’s native flora, supervising graduate theses and leading key national research projects.

Professional Profile

Google Scholar

ORCID

Education

Dr. Kendir’s academic journey began with a Bachelor’s degree in Biology from Çukurova University (completed June 15, 2001). In February 2005, she completed her MSc in Pharmaceutical Botany at Ankara University Institute of Health Sciences, with a thesis focusing on Erica species in Turkey under Prof. Dr. Ayşegül Güvenç. Advancing to doctoral studies, she earned her PhD on September 14, 2012, at the same institution, conducting pharmaceutical botanical research on Ribes species native to Turkey. Her thorough theses reflect deep proficiency in anatomical and phytochemical characterization of native Turkish medicinal plants, blending rigorous botanical investigation with pharmaceutical insights—a solid academic foundation that underpins her current scholarly work.

Work Experience

After her PhD, Dr. Kendir held a lecturer position and joined Istinye University’s Faculty of Pharmacy in 2017. By 2019, she was appointed Assistant Professor at Süleyman Demirel University’s Faculty of Pharmacy. She earned tenure as Associate Professor on January 18, 2022. Throughout her academic tenure, she has supervised MSc theses—most notably a 2018 thesis on Astragalus species—and actively participated in multiple national research projects supported by the Higher Education Council and TUBITAK, focusing on native medicinal flora. Dr. Kendir’s responsibilities encompass teaching, research, student mentorship, and active committee involvement, highlighting her versatile academic leadership.

🏆 Awards & Honors

Dr. Kendir’s scholarly contributions have earned notable recognition. In 2011, she won third prize for her poster presentation at the XII National Spectroscopy Congress. Her active involvement in prestigious national research funded by higher education institutions underscores her peer recognition. Though formal awards are limited, her leadership in these competitive projects and consistent presence at international conferences reflect growing academic respect. Participation in funded TUBITAK and national botanical studies further attest to her academic credibility and institutional esteem.

Research Focus

Speializing in pharmaceutical botany, Dr. Kendir focuses on the anatomical, biochemical, and antimicrobial properties of Turkish medicinal plants. She investigates Ribes, Erica, Opuntia, Cordia, and Laurus species through qualitative and quantitative biochemical and anatomical assessments. Her current research projects explore antibacterial and anticancer activities, biochemical profiling, and anatomical adaptations. By integrating spectrophotometric techniques, histological microscopy, and phytochemical analysis, her work bridges plant biology and pharmaceutical applications. She aims to validate traditional medicinal uses and advance the field of medicinal plant quality assessment.

Conclusion

Assoc. Prof. Dr. Gülsen Kendir exhibits all the hallmarks of a high-impact academic researcher — strong foundational knowledge, consistent scholarly output, collaborative spirit, and dedication to advancing pharmaceutical botany. Her demonstrated expertise in evaluating traditional medicinal plants and their pharmacological properties aligns well with global health priorities and natural product drug discovery. Given her prolific scientific contributions, active mentorship, and growing international footprint, she is strongly recommended for the Best Researcher Award.

Publications to Noted

Title: Etnobotanik ve Türkiye’de yapılmış etnobotanik çalışmalara genel bir bakış
Authors: G. Kendir, A. Güvenç
Citations: 275
Year: 2010

Title: Activity evaluation on Ribes species, traditionally used to speed up healing of wounds: With special focus on Ribes nigrum
Authors: G. Kendir, İ. Süntar, A.O. Çeribaşı, A. Köroğlu
Citations: 27
Year: 2019

Title: The leaf anatomy of some Erica taxa native to Turkey
Authors: A. Güvenç, G. Kendir
Citations: 19
Year: 2012

Title: In vitro antioxidant effect of the leaf and branch extracts of Ribes L. species in Turkey
Authors: G. Kendir, A. Köroğlu
Citations: 18
Year: 2015

Title: In vitro antioxidant capacities and phenolic contents of four Erica L. (Ericaceae) taxa native to Turkey
Authors: A. Köroğlu, M. Hurkul, G. Kendir, N. Küçükboyacı
Citations: 16
Year: 2019

Title: Evaluation of avocado (Persea americana Mill.) leaves in terms of public health
Authors: G. Kendir, A. Köroğlu
Citations: 15
Year: 2018

Title: Ultra-Performance Liquid Chromatography for the Simultaneous Quantification of Rutin and Chlorogenic Acid in Leaves of Ribes L. Species by Conventional and Chemometric Calibration Approaches
Authors: G. Kendir, E. Dinç, A.K. Güvenç
Citations: 13
Year: 2015

Title: Fruits, seeds and pollen morphology of Turkish Ribes L. (Grossulariaceae)
Authors: G. Kendir, A. Güvenç, A. Acar, T. Çeter, N.M. Pınar
Citations: 13
Year: 2015

Title: Evaluation of Antiviral and Antimicrobial Activities of Ribes Species Growing in Turkey
Authors: G. Kendir, A. Köroğlu, S. Özkan, S. Özgen Özgacar, T. Karaoğlu, S. Gargari
Citations: 11
Year: 2016

Title: The antibacterial effect mechanisms of Laurus nobilis extracts on carbapenem-resistant Acinetobacter baumanii isolates
Authors: S. Kızılyıldırım, T. Kandemir, G. Kendir, M.T. Muhammed, A. Köroğlu, F. Köksal, et al.
Citations: 10
Year: 2024

Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

Published on 10/06/202510/06/2025 by TOT Awards

Dr. Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

PhD Student at University of Electronic Science and Technology of China, China

Abduljabbar Salem Saeed Seror Ba Mahel is a dedicated researcher and Ph.D. candidate in Biomedical Engineering at the University of Electronic Science and Technology of China, Chengdu. His academic and research journey is driven by a passion for integrating artificial intelligence with healthcare, particularly in cardiac signal processing and medical image analysis. He has published extensively in top-tier journals and conferences, contributing innovative deep learning models for disease diagnosis, including arrhythmia detection, wound monitoring, and cancer classification. Abduljabbar’s research leverages convolutional neural networks (CNNs), recurrent units (GRUs), and transfer learning to build explainable, efficient AI tools for clinical decision support. His collaborative work spans international teams and multidisciplinary domains, underscoring his adaptability and leadership in emerging biomedical technologies. Through his work, he aims to bridge gaps in global health technology and enhance the accessibility and accuracy of diagnostic systems.

professional profile

Google Scholar

Scopus Profile

ORCID

Education

Abduljabbar Ba Mahel’s educational path reflects his commitment to academic excellence and innovation. He is currently pursuing a Ph.D. in Biomedical Engineering at the School of Life Science and Technology, University of Electronic Science and Technology of China, focusing on medical AI applications. He holds a Master of Science in Biomedical Engineering from Petersburg State Electrotechnical University, Russia, where he gained hands-on experience in neural network design for cardiac diagnostics and began contributing to scholarly research. He also completed his Bachelor of Science in Electronic Engineering at the same institution, grounding him in core electronics, signal processing, and computational tools. His interdisciplinary academic training across engineering and medical informatics provides a robust foundation for his work at the intersection of machine learning, healthcare, and signal analysis. This academic trajectory has equipped him with the skills to tackle complex biomedical challenges using advanced algorithms and cutting-edge technologies.

Work Experience

Abduljabbar Ba Mahel has cultivated a strong research-oriented career across both academic and industrial domains. As a doctoral researcher in China, he is actively engaged in multidisciplinary projects involving deep learning for ECG analysis, chronic wound monitoring, and breast cancer detection. His early research, initiated during his Master’s and Bachelor’s studies in Russia, led to contributions at IEEE conferences and collaborations with global researchers. He has also co-developed models that combine CNNs, GRUs, and attention mechanisms, many of which are now published in Frontiers in Physiology, IEEE Access, and SPIE Proceedings. With experience using platforms like TensorFlow, Keras, and PyTorch, he brings computational efficiency and clinical relevance to his work. Abduljabbar has collaborated with international teams from UAE, Russia, and Saudi Arabia, broadening his expertise in medical imaging, healthcare diagnostics, and smart health systems. He continues to push the boundaries of biomedical AI research for global health betterment.

Research Focus

Abduljabbar Ba Mahel’s research centers on the intersection of deep learning and biomedical engineering, with an emphasis on healthcare applications. His primary focus lies in developing robust AI models for ECG-based arrhythmia detection, chronic wound monitoring, and breast cancer diagnosis through medical image segmentation and signal analysis. He is deeply interested in leveraging transfer learning, domain adaptation, and attention-based architectures to improve diagnostic accuracy in real-world, imbalanced datasets. His work frequently combines CNNs, GRUs, and hybrid architectures for multi-scale feature extraction and classification. Additionally, he explores explainable AI (XAI) to enhance transparency in clinical decision-making. His contributions reflect a commitment to transforming traditional diagnostics into intelligent, automated systems that can be deployed in both high-tech hospitals and resource-limited settings. His collaborative projects span across China, Russia, and the Middle East, contributing to a globally relevant, scalable healthcare innovation portfolio.

🧠 Skills

Abduljabbar Ba Mahel possesses a rich and diverse skill set essential for modern biomedical research and AI model development. He is proficient in Python, MATLAB, R, and C++, and frequently uses frameworks such as TensorFlow, Keras, and PyTorch to implement and optimize deep learning algorithms. For scientific workflows, he is adept in Docker, Git, Jupyter, and LaTeX, enabling reproducibility and collaboration. In the medical imaging domain, he works with tools like DICOM, ITK-SNAP, and 3D Slicer for preprocessing and visualization of radiological data. He also employs statistical tools like SPSS and advanced functions in MATLAB for signal processing and hypothesis testing. His domain-specific expertise spans ECG signal classification, image segmentation, transfer learning, and synthetic data generation. With both technical and analytical strengths, Abduljabbar bridges the gap between engineering innovation and clinical application, creating end-to-end solutions for smart diagnostics and digital health systems.

Conclusion

Abduljabbar Salem Ba Mahel is a highly promising candidate for the Best Researcher Award. His body of work stands out for its depth in artificial intelligence applications in biomedical engineering and its relevance to global health challenges. With a strategic focus on integrating deep learning with medical diagnostics, he contributes to advancing digital healthcare solutions. Given his technical mastery, scholarly output, and potential for leadership in the field, he is well-suited for recognition, while also benefiting from future growth in translational impact and academic service. He embodies the spirit of innovation, making him a worthy nominee for this prestigious accolade.

Publications to Noted

Title: Recognition of life-threatening arrhythmias by ECG scalograms
Authors: A.P. Nemirko, A.S. Ba Mahel, L.A. Manilo
Citations: 8
Year: 2024

Title: Automated wound care by employing a reliable U-Net architecture combined with ResNet feature encoders for monitoring chronic wounds
Authors: M. Alabdulhafith, A.S. Ba Mahel, N. Abdel Samee, N.F. Mahmoud, R. Talaat, M.S. Muthanna, T.M. Nassef
Citations: 6
Year: 2024

Title: Arrhythmia classification using AlexNet model based on orthogonal leads and different time segments
Authors: A.S.B. Mahel, N. Harold, H. Solieman
Citations: 6
Year: 2022

Title: Classification of cardiac cycles using a convolutional neural network
Authors: A.S.B. Mahel, A.N. Kalinichenko
Citations: 6
Year: 2022

Title: Advanced integration of 2DCNN-GRU model for accurate identification of shockable life-threatening cardiac arrhythmias: a deep learning approach
Authors: A.S. Ba Mahel, S. Cao, K. Zhang, S. Chelloug, R. Alnashwan, M.S. Muthanna
Citations: 5
Year: 2024

Title: Classification of arrhythmia using parallel channels and different features
Authors: A.S.B. Mahel, A.N. Kalinichenko
Citations: 5
Year: 2024

Title: The role of synthetic data in mitigating imbalance in deep-learning-based arrhythmia classification: a comparative study
Authors: A.S.B. Mahel, F.M.G. Alotaibi, N. Rao
Citations: 1
Year: 2024

Title: Распознавание опасных аритмий по скалограммам ЭКГ
Authors: А.П. Немирко, А.С. Ба Махел, Л.А. Манило
Citations: 1
Year: 2024

Title: Optimizing Monkeypox Lesions Detection with a Lightweight Hybrid Model
Authors: M.S.A.M. Al-Gaashani, R. Alkanhel, D.S.M. Hassan, A.S.B. Mahel, A. Aziz, M.M. Khayyat, A. Muthanna
Citations: 0 (recent)
Year: 2025

Title: A multi-scale deep learning framework combining MobileViT-ECA and LSTM for accurate ECG analysis
Authors: A.S.B. Mahel, M.S.A.M. Al-Gaashani, R.I. Alkanhel, D.S.M. Hassan, A. Muthanna, A. Aziz
Year: 2025

Shahinaz Mohamed | Clinical Research | Best Researcher Award

Published on 04/03/202504/03/2025 by TOT Awards

Dr. Shahinaz Mohamed | Clinical Research | Best Researcher Award

Clinical Research Assistant at King Abdullah International Medical Research Center, Saudi Arabia

Dr. Shahinaz F. Mohamed is a highly experienced Medical Writer and Clinical Research Professional with over 12 years of expertise in the medical research field. She holds a Master of Public Health (MPH) from the University of Essex, UK, and is a Certified Clinical Research Associate (CCRA®). With a strong background in clinical trials, medical writing, and regulatory compliance, she has played a pivotal role in developing and managing clinical study protocols, ethical review processes, and scientific publications. Currently, she serves as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia. Dr. Mohamed has significantly contributed to peer-reviewed medical journals, showcasing her expertise in public health, evidence-based medicine, and digital health research. Her work in Good Clinical Practice (GCP) training, clinical trial documentation, and regulatory compliance has established her as a key figure in the field of clinical and translational research.

professional profiles

ORCID

Google scholar

Education

Dr. Shahinaz Mohamed has a diverse and well-rounded educational background in public health, clinical research, and medical sciences. She earned her Master of Public Health (MPH) from the University of Essex, UK, in 2019, which provided her with a strong foundation in epidemiology, healthcare policy, and biostatistics. She further enhanced her qualifications by obtaining the Certified Clinical Research Associate (CCRA®) from the USA in 2022, demonstrating her expertise in clinical trials and regulatory compliance. Additionally, she holds a Certified Clinical Research Coordinator (CCRC®) certification from KSA (2013), further establishing her credibility in research methodology and ethical compliance. Her academic journey began with a Diploma of Higher Education in Histopathology from Egypt (2006) and a Bachelor of Veterinary Medicine from Egypt (2004), providing her with deep knowledge in biomedical sciences and medical research. Her comprehensive education has equipped her with the skills necessary for high-quality clinical research and medical writing.

work Experience

Dr. Shahinaz Mohamed has been an integral part of the clinical research field for over a decade, primarily serving as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia, since 2011. In this role, she has been responsible for developing clinical study protocols, drafting case report forms, and preparing informed consent documents. She has also played a key role in the scientific and ethical evaluation of research proposals for Institutional Review Board (IRB) approval, ensuring compliance with Good Clinical Practice (GCP) and international regulatory standards. Her work includes conducting literature reviews, statistical analysis, and data interpretation for scientific publications, as well as peer-reviewed journal articles and systematic reviews. In addition, she has contributed as a Research Proposal Reviewer and IRB Member, evaluating preclinical and clinical studies and advising investigators on study design, ethical considerations, and publication guidelines.

Research Focus

Dr. Shahinaz Mohamed’s research primarily focuses on infectious diseases, clinical trials, endocrinology, and public health. Her work in infectious disease epidemiology has contributed to the treatment and management of conditions such as Middle East respiratory syndrome (MERS-CoV) and diabetes. She has played a vital role in clinical trials and evidence-based medicine, ensuring the development of robust interventional studies to improve patient outcomes. In the field of endocrinology and metabolic disorders, she has examined the impact of insulin therapy and lipid metabolism in diabetes patients. Additionally, her research extends to medical ethics and GCP compliance, ensuring that clinical trials adhere to the highest ethical standards. She has also been actively involved in digital health and healthcare data analysis, exploring the adoption of personal health records and AI-driven medical research solutions. Her multidisciplinary research contributes to medical advancements and improved healthcare policies.

Awards & Honors🏆

Dr. Shahinaz Mohamed has been recognized for her significant contributions to clinical research and medical writing through various awards and honors. She earned the prestigious Certified Clinical Research Associate (CCRA®) certification from the USA in 2022, affirming her expertise in clinical trials and research ethics. Additionally, she has been an ICH-GCP Instructor and Certification Trainer, providing Good Clinical Practice (GCP) training for medical professionals. She has been invited as a presenter at Research Methodology & Biostatistics Workshops (Nature Research Academies, 2022) and has served as a Clinical Research Capability Trainer for AstraZeneca in 2022. Her participation as a speaker at Annual Clinical Research Symposiums (KAIMRC, Almoosa Specialist Hospital) further highlights her influence in the medical research community. Recognized for her expertise in Regulatory & Quality Management in Clinical Research (SFDA, FDA compliance), she continues to be a key figure in clinical research training and regulatory affairs.

Skills 🛠️

Dr. Shahinaz Mohamed possesses a diverse skill set that allows her to excel in clinical research, scientific writing, and regulatory compliance. She is highly proficient in medical and scientific writing, specializing in manuscripts, abstracts, and study protocols. Her expertise in clinical research methodology and statistical analysis (SPSS, STATA, R) enables her to conduct comprehensive data analysis and interpretation. She is skilled in Institutional Review Board (IRB) submissions and compliance, ensuring ethical approval of clinical trials. Additionally, she is a Good Clinical Practice (GCP) instructor, providing training in research ethics and regulatory compliance. Her proficiency in systematic reviews, manuscript editing, and peer-review coordination makes her a highly sought-after expert in medical publishing. She is also well-versed in digital health research and AI-driven healthcare solutions, contributing to the advancement of innovative medical technologies. With fluency in English and Arabic, she effectively communicates research findings and regulatory guidelines across diverse medical communities.

Conclusion

Publications to Noted

Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

Authors: YM Arabi, A Alothman, HH Balkhy, A Al-Dawood, S AlJohani, S Al Harbi, …

Citations: 370

Year: 2018

Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis

Authors: M Zou, AS Alzahrani, A Al-Odaib, MA Alqahtani, O Babiker, RA Al-Rijjal, …

Citations: 72

Year: 2018

Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting

Authors: MD Reem Alamoudi, MD, MHSc, Maram Alsubaiee, MD, Ali Alqarni, MD, Yousef …

Citations: 39

Year: 2017

Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial

Authors: Y Arabi, F Al-Hameed, KEA Burns, S Mehta, S Alsolamy, M Almaani, …

Citations: 14

Year: 2018

The Dialysis Outcomes and Practice Patterns Study Phase 5 in the Gulf Cooperation Council Countries Design and Study Methods

Authors: Pisoni, Ronald L., BA Bieber, J Al Wakeel, S Al Arrayed, N Alkandari, …

Citations: 11

Year: 2016

Surveillance or no surveillance for deep venous thrombosis and outcomes of critically ill patients: a study protocol and statistical analysis plan

Authors: YM Arabi, KEA Burns, F Al-Hameed, S Alsolamy, M Almaani, …

Citations: 7

Year: 2018

Replacing protein via enteral nutrition in a stepwise approach in critically ill patients: the REPLENISH randomized clinical trial protocol

Authors: YM Arabi, HM Al-Dorzi, M Sadat, D Muharib, H Algethamy, F Al-Hameed, …

Citations: 6

Year: 2023

The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure

Authors: HM Al-Dorzi, A Al-Dawood, FM Al-Hameed, KEA Burns, S Mehta, J Jose, …

Citations: 5

Year: 2022

Statistical analysis plan for the replacing protein via enteral nutrition in a stepwise approach in critically ill patients (REPLENISH) randomized clinical trial

Authors: YM Arabi, HM Al-Dorzi, O Aldibaasi, M Sadat, J Jose, D Muharib, …

Citations: 3

Year: 2024

Association of advanced lipoprotein subpopulation profiles with insulin resistance and inflammation in patients with type 2 diabetes Mellitus

Authors: A Bakillah, KK Obeid, M Al Subaiee, AF Soliman, M Al Arab, SF Bashir, …

Citations: 3

Year: 2023

Heng Zhang | Biomedical Research | Best Researcher Award

Published on 14/02/202514/02/2025 by TOT Awards

Dr. Heng Zhang | Biomedical Research | Best Researcher Award

Research Scientist at Versiti Blood Research Institute, United States

Dr. Heng Zhang is a Research Scientist specializing in integrin structure and signaling at the Blood Research Institute, Versiti, U.S. His expertise spans biochemical and structural biology, molecular genetics, and biotechnology. With a strong academic background from Waikato University and Shandong Normal University, he has contributed significantly to the fields of virology, protein interactions, and blood-related research. His work includes pioneering studies on integrins, viral receptors, and hemophilia mutations. Dr. Zhang has received numerous prestigious awards and serves as a reviewer for scientific journals. His research has led to patents and publications in high-impact journals, demonstrating his commitment to advancing biomedical science.

professional profiles

Scopus Profile

ORCID

Education

Dr. Zhang earned his Ph.D. in Biochemical and Structural Biology from Waikato University, New Zealand, in 2019, where he focused on protein structure and function, particularly in relation to bovine salivary proteins and microbial interactions. Before that, he obtained an M.Sc. in Molecular Genetics with First-Class Honors from Waikato University, specializing in genetic and biochemical approaches to understanding molecular pathways. His academic journey began at Shandong Normal University, China, where he completed a B.Sc. in Biotechnology in 2009, gaining foundational knowledge in biotechnology, molecular biology, and genetic engineering.

work Experience

Currently, Dr. Zhang serves as a Research Scientist at the Blood Research Institute, Versiti, where he investigates integrin structure and signaling. Previously, he worked as a Postdoctoral Fellow at the same institute from 2019 to 2023, focusing on molecular mechanisms in virology and blood coagulation. His experience also includes teaching molecular biology and biochemistry as a Teaching Assistant at Waikato University from 2013 to 2019, where he mentored students and supported laboratory research. Additionally, he worked as a Research Technologist at Waikato University from 2013 to 2014, conducting laboratory experiments related to protein structure and microbial interactions.

🏆 Awards and Honors

Dr. Zhang has received multiple accolades throughout his career. In 2024, he was honored with the Education Committee Award from Versiti Blood Research Institute. During his graduate studies, he earned the DairyNZ Graduate Student Award from AgResearch Ltd (2015-2019) and multiple internal awards from Waikato University in 2014 and 2012. His academic excellence was recognized early on with First and Second Class Scholarships from Shandong Normal University (2005-2009) and a Second Prize award in the China High School Biology Olympiad in 2003.

Skills

Dr. Zhang is highly skilled in structural biology, with expertise in X-ray crystallography, cryo-EM, and protein modeling. He has strong computational biology skills, using tools such as AlphaFold and molecular dynamics simulations. His biochemical expertise includes protein purification, enzyme kinetics, and cellular assays, while his genetic engineering experience covers CRISPR, recombinant protein expression, and cloning. As an active contributor to the scientific community, he serves as a reviewer for Frontiers in Cardiovascular Medicine and has been involved in patent development for antiviral receptor-based technologies.

Research Focus

Dr. Zhang’s research revolves around integrin structure and signaling, exploring mechanisms of cell adhesion and immune response regulation. He has made significant contributions to understanding hemophilia and blood disorders, utilizing computational modeling to study coagulation factors. His work in virology includes investigating cell-attachable viral receptors for infectious disease control. Additionally, he applies structural biology techniques, including cryo-EM and AlphaFold-based predictions, to study protein interactions. His research extends to biomedical engineering and drug development, with a focus on innovative therapeutic approaches for blood-related diseases.

Conclusion

Publications to Noted

Predicting the effects of single pathological mutations in Hemophilia A and Type 2N Von Willebrand Diseases using AlphaFold2‐multimer and AlphaFold3

Authors: Not provided

Citations: Not provided

Year: 2025

Facilitating and restraining virus infection using cell‐attachable soluble viral receptors

Authors: Not provided

Citations: Not provided

Year: 2024

Integrin α 5 β 1 contributes to cell fusion and inflammation mediated by SARS‐CoV‐2 spike via RGD‐independent interaction

Authors: Not provided

Citations: Not provided

Year: 2023

Family‐wide analysis of integrin structures predicted by AlphaFold2.

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2023

Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes

Authors: Not provided

Citations: Not provided

Year: 2023

Coagulopathy in COVID‐19 and anticoagulation clinical trials

Authors: Not provided

Citations: Not provided

Year: 2022

The three dimensional structure of Bovine Salivary Protein 30b (BSP30b) and its interaction with specific rumen bacteria.

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2019

A new method to extract and purify DNA from allophanic soils and paleosols, and potential for paleoenvironmental reconstruction and other applications

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016

What can the geographic distribution of mtDNA haplotypes tell us about the invasion of New Zealand by house mice Mus musculus?

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016

DNA adsorption by nanocrystalline allophane spherules and nanoaggregates, and implications for carbon sequestration in Andisols

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016